Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Araujo DV"'
Autor:
Gagnon-Arpin, I, Bahia, LR, Araujo, DV, Sutherland, G, Dobrescu, A, Villa, G, Habib, M, dos Santos, RF
Publikováno v:
In Value in Health October-November 2017 20(9):A612-A612
Autor:
Sachetti CG; Graduate Program for Collective Health, Faculty of Health Sciences, University of Brasilia (UnB), Brasilia, Brazil; Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil. Electronic address: camile.sachetti@fiocruz.br., Barbosa A Jr; Departament of Hemotherapy and Cell Therapy, Israelita Albert Einstein Hospital, São Paulo, Brazil., de Carvalho ACC; Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Araujo DV; Medical School, State University of Rio de Janeiro, Rio de Janeiro, Brazil., da Silva EN; Graduate Program for Collective Health, Faculty of Health Sciences, University of Brasilia (UnB), Brasilia, Brazil; Collective Health School, Faculty of Ceilandia, University of Brasilia, Brasília, Brazil.
Publikováno v:
Cytotherapy [Cytotherapy] 2024 Aug; Vol. 26 (8), pp. 939-947. Date of Electronic Publication: 2024 Mar 29.
Autor:
Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto. Electronic address: anna.spreafico@uhn.ca., Heirali AA; Toronto General Hospital Research Institute, University Health Network, Toronto, Canada., Araujo DV; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto; Department of Medical Oncology, Hospital de Base, Sao Paulo, Brazil., Tan TJ; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Oliva M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto; Department of Medical Oncology, Institut Catala d' Oncologia, L'Hospitalet de Llobregat, Barcelona; Universitat de Barcelona, Barcelona, Spain., Schneeberger PHH; Toronto General Hospital Research Institute, University Health Network, Toronto, Canada; Swiss Tropical and Public Health Institute, Department of Medical Parasitology and Infection Biology, Allschwil; University of Basel, Basel, Switzerland., Chen B; Biostatistics Department, Princess Margaret Cancer Centre, University Health Network, Toronto., Wong MK; Department of Immunology, University of Toronto, Toronto., Stayner LA; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto., Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto., Saibil SD; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto., Wang BX; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto., Cochrane K; Nubiyota LLP, Guelph, Canada., Sherriff K; Nubiyota LLP, Guelph, Canada., Allen-Vercoe E; Nubiyota LLP, Guelph, Canada., Xu W; Biostatistics Department, Princess Margaret Cancer Centre, University Health Network, Toronto., Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto., Coburn B; Toronto General Hospital Research Institute, University Health Network, Toronto, Canada. Electronic address: Bryan.Coburn@uhn.ca.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Jun; Vol. 34 (6), pp. 520-530. Date of Electronic Publication: 2023 Mar 01.
Autor:
Sanz-Garcia E; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Genta S; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Chen X; Geneseeq Technology Inc, Toronto, Canada., Ou Q; Geneseeq Technology Inc, Toronto, Canada., Araujo DV; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada.; Division of Medical Oncology, Hospital de Base, Sao Paulo, Brazil., Abdul Razak AR; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Hansen AR; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Spreafico A; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Bao H; Geneseeq Technology Inc, Toronto, Canada., Wu X; Geneseeq Technology Inc, Toronto, Canada., Siu LL; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Bedard PL; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2023 Apr; Vol. 7, pp. e2200509.
Autor:
Hernando-Calvo A; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Salawu A; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Chen RY; Princeton University, NJ, USA., Araujo DV; Department of Medical Oncology, Hospital de Base, Sao Jose do Rio Preto, SP, Brazil., Oliva M; Department of Medical Oncology, Institut Català D'Oncologia (ICO) L'Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Liu ZA; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Siu LL; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada. Electronic address: Lillian.siu@uhn.ca.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Nov; Vol. 175, pp. 11-18. Date of Electronic Publication: 2022 Sep 06.
Autor:
Salawu A; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Hernando-Calvo A; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Chen RY; Princeton University, New Jersey, USA., Araujo DV; Department of Medical Oncology, Hospital de Base, Sao Jose do Rio Preto, SP, Brazil., Oliva M; Department of Medical Oncology, Institut Català D'Oncologia (ICO) L´Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Liu ZA; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Siu LL; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada. Electronic address: Lillian.siu@uhn.ca.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Sep; Vol. 173, pp. 167-177. Date of Electronic Publication: 2022 Jul 21.
Autor:
Araujo DV; Medical Oncology Department, Hospital de Base, São José do Rio Preto, Brazil. Electronic address: daniel.araujo@edu.famerp.br., Soler JA; Medical Oncology Department, Hospital de Base, São José do Rio Preto, Brazil., Cordeiro de Lima VC; Medical Oncology Department, AC Camargo Cancer Center, São Paulo, Brazil.
Publikováno v:
Med (New York, N.Y.) [Med] 2022 Jul 08; Vol. 3 (7), pp. 445-449.
Autor:
Araujo DV; Department of Medical Oncology, Hospital de Base/HB Onco, FUNFARME/FAMERP, Av. Brigadeiro Faria Lima 5544, São José do Rio Preto, SP, Brazil. daniel.araujo@edu.famerp.br., Uchoa B; Department of Medical Oncology, Hospital de Base/HB Onco, FUNFARME/FAMERP, Av. Brigadeiro Faria Lima 5544, São José do Rio Preto, SP, Brazil., Soto-Castillo JJ; Department of Medical Oncology, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain., Furlan LL; Department of Medical Oncology, Hospital de Base/HB Onco, FUNFARME/FAMERP, Av. Brigadeiro Faria Lima 5544, São José do Rio Preto, SP, Brazil., Oliva M; Department of Medical Oncology, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain. moliva@iconcologia.net.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. moliva@iconcologia.net.
Publikováno v:
Targeted oncology [Target Oncol] 2022 May; Vol. 17 (3), pp. 253-270. Date of Electronic Publication: 2022 Jun 10.
Autor:
Muniz TP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Araujo DV; Hospital de Base, Faculdade de Medicina de Sao Jose do Rio Preto, Sao Jose do Rio Preto 15090-000, Brazil., Savage KJ; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC V5Z 1M9, Canada., Cheng T; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada., Saha M; Division of Endocrinology and Metabolism, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada., Song X; The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON K1H 8L6, Canada., Gill S; Division of Endocrinology and Metabolism, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada., Monzon JG; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada., Grenier D; Department of Medical Oncology, University of Manitoba, Winnipeg, MB R3A 1R9, Canada., Genta S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Allen MJ; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Arteaga DP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Saibil SD; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Butler MO; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Hogg D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Dec 24; Vol. 14 (1). Date of Electronic Publication: 2021 Dec 24.
Autor:
Kubli SP; Ontario Cancer Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Berger T; Ontario Cancer Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Araujo DV; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Mak TW; Ontario Cancer Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. tmak@uhnres.utoronto.ca.; Department of Immunology, University of Toronto, Toronto, ON, Canada. tmak@uhnres.utoronto.ca.; Department of Pathology, University of Hong Kong, Hong Kong, Hong Kong. tmak@uhnres.utoronto.ca.
Publikováno v:
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2021 Dec; Vol. 20 (12), pp. 899-919. Date of Electronic Publication: 2021 Mar 08.